Exchange: NASDAQ·Updated 05:45 PM EDT
AXSM logo

AXSMAxsome Therapeutics Inc

$249.00
$3.38
(1.38%)
Today
Closed $248.95
$0.05
(0.02%)
After Hours
EarningsAug 3
Mkt Cap$12.64B
Vol621,707.00
News
all
press releases
Axsome Begins Phase III Study on Solriamfetol for ADHD in Children
AXSM doses the first patient in the phase III FOCUS-2 study of solriamfetol for treating ADHD in children aged six to under 12 years.
Zacks
News Placeholder
More News
News Placeholder
Is Axsome Therapeutics Stock a Millionaire Maker? Here's What the Numbers Say.
Key PointsAxsome specializes in central nervous system disorders, including depression, migraine, and fibromyalgia...
Nasdaq News: Markets
News Placeholder
TARS Stock Drops After Culper Research Accuses Tarsus Of Illegal Medicare Copay Scheme
Culper’s central allegation is that Tarsus has driven XDEMVY uptake among Medicare patients by funding copay assistance.
Stocktwits
News Placeholder
Harmony Biosciences Stock Outlook as Wakix Growth Meets Pipeline
Harmony Biosciences is leveraging Wakix growth to expand its neuroscience pipeline, while advancing pitolisant programs and rare disease assets.
Zacks
News Placeholder
Why Is Mirum Pharmaceuticals (MIRM) Down 10.1% Since Last Earnings Report?
Mirum Pharmaceuticals (MIRM) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Zacks
News Placeholder
Why Is Ocugen (OCGN) Down 10.7% Since Last Earnings Report?
Ocugen (OCGN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Zacks
News Placeholder
Why Is Axsome (AXSM) Down 0.4% Since Last Earnings Report?
Axsome (AXSM) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Zacks
News Placeholder
Insider Selling: Axsome Therapeutics (NASDAQ:AXSM) COO Sells 233 Shares of Stock
Axsome Therapeutics, Inc. (NASDAQ:AXSM - Get Free Report) COO Mark Jacobson sold 233 shares of the stock in a transaction on Tuesday, May 5th. The stock was sold at an average price of $228.18, for a total value of $53,165.94. Following the transaction, the chief operating officer owned 4,517...
MarketBeat
News Placeholder
Mark Jacobson Sells 4,517 Shares of Axsome Therapeutics (NASDAQ:AXSM) Stock
Axsome Therapeutics, Inc. (NASDAQ:AXSM - Get Free Report) COO Mark Jacobson sold 4,517 shares of the firm's stock in a transaction dated Monday, May 4th. The stock was sold at an average price of $227.94, for a total transaction of $1,029,604.98. Following the sale, the chief operating officer...
MarketBeat
News Placeholder
AXSM Q1 Loss Widens, Revenues Jump on Higher Auvelity Sales
Axsome posts a wider Q1 loss but revenues jump 57%, driven by strong Auvelity and Sunosi sales.
Zacks
<
1
2
...
>

Advertisement|Remove ads.